Search

Your search keyword '"Guilherme Jorge Costa"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Guilherme Jorge Costa" Remove constraint Author: "Guilherme Jorge Costa" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
16 results on '"Guilherme Jorge Costa"'

Search Results

1. Post-COVID 19 syndrome and quality of life in women

2. Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study

Catalog

Books, media, physical & digital resources

4. Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study

5. Letter from Brazil

6. Circulating levels of Galectin 9 are a potential biomarker predictive of overall survival in patients with advanced Non-Small-Cell Lung Cancer

7. Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data

8. The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data

9. Malignant pleural mesothelioma in Brazil: An analysis of public databases between 2000 and 2017

10. Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil

11. Could soluble levels of CD40L and galectin-9 be possible prognostic biomarkers and therapeutic targets in NSCLC?

12. Former smokers as the most frequent smoking status in patients with lung cancer in Brazil

13. Tumor-node-metastasis staging and treatment patterns of 73,167 patients with lung cancer in Brazil

14. Increased incidence, morbidity and mortality rates for lung cancer in women in Brazil between 2000 and 2014: An analysis of three types of sources of secondary data

15. Response to 'Commentary on: Undertreatment trend in elderly lung cancer patients in Brazil'-Jing-lan Tang, Chun-jie Hou

16. Concurrent chemoradiotherapy for stage III non-small cell lung cancer: correct clinical management as the basis to move beyond